Uncategorized

Long-term metastatic melanoma survival dramatically improves on immunotherapy, clinical trial finds – Medical Xpress

Long-term metastatic melanoma survival dramatically improves on immunotherapy, clinical trial finds  Medical XpressHalf of advanced melanoma patients live for 10 years with double drug treatment  The GuardianNew skin cancer treatment helps patients live 10 years after diagnosis, study finds  The TelegraphImmunotherapy Drugs Extend Survival for Patients With Advanced Melanomas  U.S. News & World ReportNeoadjuvant Immunotherapy Superior to Targeted Therapy in Stage III Melanoma  AJMC.com Managed Markets Network